Related Experiment Video
Updated: Apr 25, 2026

Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
Reduction of sulfamethoxazole hydroxylamine (SMX-HA) by the mitochondrial amidoxime reducing component (mARC)
Gudrun Ott1, Birte Plitzko, Carmen Krischkowski
1Department of Pharmaceutical and Medicinal Chemistry, Pharmaceutical Institute, Christian-Albrechts-University of Kiel , Gutenbergstrasse 76, D-24118 Kiel, Germany.
Abstract:
Under high dose treatment with sulfamethoxazole (SMX)/trimethoprim (TMP), hypersensitivity reactions occur with a high incidence. The mechanism of this adverse drug reaction is not fully understood. Several steps in the toxification pathway of SMX were investigated. The aim of our study was to investigate the reduction of sulfamethoxazole hydroxylamine (SMX-HA) in this toxification pathway, which can possibly be catalyzed by the mARC-containing N-reductive enzyme system. Western blot analyses of subcellular fractions of porcine tissue were performed with antibodies against mARC-1, mARC-2, cytochrome b5 type B, and NADH cytochrome b5 reductase. Incubations of porcine and human subcellular tissue fractions and of the heterologously expressed human components of the N-reductive enzyme system were carried out with SMX-HA. mARC-1 and mARC-2 knockdown was performed in HEK-293 cells. Kinetic parameters of the heterologously expressed human protein variants V96L, A165T, M187 K, C246S, D247H, and M268I of mARC-1 and G244S and C245W of mARC-2 and N-reductive activity of 2SF, D14G, K16E, and T22A of cytochrome b5 type B were analyzed. Western blot analyses were consistent with the hypothesis that the mARC-containing N-reductive enzyme system might be involved in the reduction of SMX-HA. In agreement with these results, highest reduction rates were found in mitochondrial subcellular fractions of porcine tissue and in the outer membrane vesicle (OMV) of human liver tissue. Knockdown studies in HEK-293 cells demonstrated that mARC-1 and mARC-2 were capable of reducing SMX-HA in cell metabolism. Investigations with the heterologously expressed human mARC-2 protein showed a higher catalytic efficiency toward SMX-HA than mARC-1, but none of the investigated human protein variants showed statistically significant differences of its N-reductive activity and was therefore likely to participate in the pathogenesis of hypersensitivity reaction under treatment with SMX.
Insights
The mARC enzyme system may reduce sulfamethoxazole hydroxylamine (SMX-HA), a step in sulfamethoxazole (SMX) drug toxicity. While mARC-1 and mARC-2 reduce SMX-HA, human variants did not show significant differences in activity.
Area of Science:
- Biochemistry
- Pharmacology
- Toxicology
Background:
- High-dose sulfamethoxazole (SMX)/trimethoprim (TMP) treatment is linked to frequent hypersensitivity reactions.
- The precise mechanism underlying these adverse drug reactions remains incompletely understood.
- Investigating the toxification pathway of SMX is crucial for understanding its adverse effects.
Purpose of the Study:
- To investigate the potential role of the mARC-containing N-reductive enzyme system in the reduction of sulfamethoxazole hydroxylamine (SMX-HA).
- To explore the involvement of mARC-1 and mARC-2 in the SMX toxification pathway.
- To analyze the kinetic parameters of human mARC-1 and mARC-2 variants in relation to SMX-HA reduction.
Main Methods:
- Western blot analyses of porcine tissue subcellular fractions using antibodies against mARC-1, mARC-2, cytochrome b5 type B, and NADH cytochrome b5 reductase.
- Incubation studies with SMX-HA using porcine and human subcellular tissue fractions and heterologously expressed human N-reductive enzyme system components.
- mARC-1 and mARC-2 knockdown in HEK-293 cells and kinetic analysis of expressed human protein variants.
Main Results:
- Western blot results supported the hypothesis that the mARC-containing N-reductive enzyme system is involved in SMX-HA reduction.
- Highest reduction rates of SMX-HA were observed in mitochondrial fractions of porcine tissue and outer membrane vesicles of human liver tissue.
- Knockdown studies confirmed that mARC-1 and mARC-2 can reduce SMX-HA in cellular metabolism, with mARC-2 exhibiting higher catalytic efficiency than mARC-1.
Conclusions:
- The mARC-containing N-reductive enzyme system plays a role in the reduction of SMX-HA.
- While mARC-1 and mARC-2 are capable of reducing SMX-HA, investigated human variants did not show significant differences in N-reductive activity.
- Further research is needed to fully elucidate the role of these enzymes and their variants in SMX-induced hypersensitivity reactions.
More Related Videos
08:03Unveiling Xenobiotic Transport and Effects in Isolated Mitochondria: Insights from Respirometric and Enzymatic Assays
Published on: March 7, 2025
08:57Simultaneous Measurement of Superoxide/Hydrogen Peroxide and NADH Production by Flavin-containing Mitochondrial Dehydrogenases
Published on: February 24, 2018
Related Concept Videos
Preparation of Amines: Reduction of Oximes and Nitro Compounds
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Phase I Reactions: Reductive Reactions
Preparation of Amines: Reductive Amination of Aldehydes and Ketones
Drug Metabolism: Phase II Reactions
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Preparation of Amines: Reduction of Amides and Nitriles
Amides can be reduced to primary, secondary, and tertiary amines using catalytic hydrogenation, active metals like Fe,...